A network meta-analysis of efficacy and safety of adjuvant targeted therapy or immunotherapy in non-small cell lung cancer

A network meta-analysis of efficacy and safety of adjuvant targeted therapy or immunotherapy in non-small cell lung cancer

Abstract The integration of targeted therapy and immunotherapy into adjuvant treatments for early-stage non-small cell lung cancer (NSCLC) remains challenging. This study aimed to compare the efficacy and safety of all available adjuvant treatment options. Randomized controlled trials (RCTs) publish...

Full description

Saved in:
Bibliographic Details
Main Authors: Sunatee Sa-nguansai, Sasivimol Rattanasiri, Prapaporn Pornsuriyasak, Pawin Numthavaj, Gareth J. McKay, John Attia, Ammarin Thakkinstian
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Non-small cell lung cancer
Adjuvant therapy
Targeted therapy
Immunotherapy
Network meta-analysis
Disease-free survival
Online Access:https://doi.org/10.1038/s41598-025-05823-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-05823-2

Similar Items